https://www.pharmaceutical-technology.com/data-insights/ivosidenib-les-laboratoires-servier-low-grade-glioma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-217199&utm_campaign=recommended-articles-pi
Ivosidenib is under clinical development by Les Laboratoires Servier and currently in Phase I for Low-Grade Glioma.
les laboratoires servierlow grade gliomaivosideniblikelihood